Home 新闻中心新闻

新闻

帮您了解冠科生物的最新资讯.

Crown Bioscience Passes 1000 Model Mark in PDX Collection for Oncology Drug Discovery

April 22, 2014

Crown Bioscience to Showcase Novel “in life” Platforms for Oncology and Metabolic Disease Drug Discovery at the AACR Annual Meeting 2014

February 14, 2014

Shanghai Institute of Materia Medica and Crown Bioscience Reach Landmark Agreement to Develop World-leading Mouse Clinical Center and Largest Annotated PDX and Translational Oncology Platform

November 26, 2013

Crown Bioscience Enhances Oncology Research Services with Targeted Beam Radiation Therapy via Business Collaboration with Xstrahl Ltd

October 15, 2013

Crown Bioscience Strengthens Oncology Expertise with Acquisition of PRECOS Ltd

July 30, 2013

Crown Bioscience, Inc. and Horizon Discovery Announce Exclusive Two Year Agreement to Offer Combined Solutions for In Vivo Drug Discovery Model Development

April 3, 2013

Crown Bioscience, Inc. and Horizon Discovery, Ltd. to Showcase X-MAN Cell Lines for In Vivo and In Vitro Drug Discovery Model Validation at EORTC-NCI-AACR Symposium

November 6, 2012

Crown Bioscience, Inc. Enters into Strategic Partnership with Jiangsu Hengrui Medicine Co., Ltd. for the Discovery and Commercialization of Novel Therapeutic Monoclonal Antibodies

January 11, 2012

Crown Bioscience Expands Distribution Network – Appoints On Target Co, Ltd. as Sales Representative in Japan to Enable Access to Translational Oncology Assets

April 11, 2011

Allostem Therapeutics Teams with Crown Biosciences for Phase 0 Oncology Model Selection to Accelerate MEK Inhibitor Program

April 1, 2011

© 2025 Crown Bioscience.

中美冠科生物技术(太仓)有限公司苏ICP备10097610号